A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in human epidermal growth factor receptor 2 positive (HER2+) early breast cancer (EBC) in China: Updated interim analysis from the NER-Tree study.

Xiaojia Wang, Jin Zhang, Haiguang Liu et al.|Journal of Clinical Oncology|2025

Cited by 0